Responsiveness of continuous ratings of dyspnea during exercise in patients with COPD

Medicine and Science in Sports and Exercise

Volumn 37, Issue 4, 2005, Pages 529-535

  Mahler, Donald A ^a,b   Fierro Carrion, Gustavo ^a,d   Mejia Alfaro, Roberto ^a,e   Ward, Joseph ^b   Baird, John C ^a,c  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c Psychological Applications   (United States)

^d Natl Inst of Respiratory Diseases ^*

^e INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

Bronchodilator therapy; Cardiopulmonary exercise testing; Measurement of breathlessness; Obstructive airway disease; Pulmonary function testing

Indexed keywords

BRONCHODILATING AGENT; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; SALBUTAMOL;

ADULT; AGED; ARTICLE; BICYCLE ERGOMETER; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DYSPNEA; EXERCISE; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; MALE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; WORK CAPACITY;

AGED; ALBUTEROL; BRONCHODILATOR AGENTS; COMPUTERS; DOUBLE-BLIND METHOD; DYSPNEA; EXERCISE TEST; FEMALE; HUMANS; IPRATROPIUM; LINEAR MODELS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SPIROMETRY; TIME FACTORS;

EID: 16444380940     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1249/01.MSS.0000158188.90833.38     Document Type: Article

References (30)

1. AMERICAN THORACIC SOCIETY. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 152:S77-S120, 1995.
2. ANTHONISEN, N. R., E. C. WRIGHT, and THE IPPB TRIAL GROUP. Bronchodilator response in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 133:814-819, 1986.
3. AYERS, M. L., R. MEJIA, J. WARD, T. LENTINE, and D. A. MAHLER. Effectiveness of salmeterol versus ipratropium bromide on exertional dyspnea in COPD. Eur. Respir. J. 17:1132-1137, 2001.
4. BAIRD, J. C. Sensory psychophysics. In: Self-Management of Asthma, H. Kotses and A. Harver (Eds.). New York: Marcel Dekker, Inc., 1998, pp. 231-267.
5. BATES, D. V., P. T. MACKLEM, and R. V. CHRISTIE. Respiratory Function and Disease, 2nd Ed. Philadelphia: W. B. Saunders, 1971, pp. 10-95.
6. BELMAN, M. J., W. C. BOTNICK, and J. W. SHIN. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 153:967-975, 1996.
7. BORG, G. A. Psychophysical bases of perceived exertion. Med. Sci. Sports Exerc. 14:377-381, 1982.
8. BUCHFUHRER, M., J. E. HANSEN, T. E. ROBINSON, D. Y. SUE, K. WASSERMAN, and B. J. WHIPP. Optimizing the exercise protocol for cardiopulmonary assessment. J. Appl. Physiol. 55:1558-1564, 1983.
9. CALVERLY, P. M. A., P. S. BURGE, S. SPENCER, J. A. ANDERSON, and P. W. JONES. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 58:659-664, 2003.
10. CELLI, B. R., W. MACNEE, and COMMITTEE MEMBERS. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 23:932-946, 2004.
11. CRAPO, R. O., A. H. MORRIS, and R. M. GARDNER. Reference spirometry values using techniques and equipment that meets ATS recommendations. Am. Rev. Respir. Dis. 123:659-664, 1981.
12. DILLARD, T. A., S. PIANTADOSI, and K. R. RAJAGOPAL. Prediction of ventilation at maximal exercise in chronic air-flow obstruction. Am. Rev. Respir. Dis. 132:230-235, 1985.
13. FABBRI, L., R. A. PAUWELS, and S. S. HURD ON BEHALF OF THE GOLD SCIENTIFIC COMMITTEE. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary updated 2003. J. COPD 1:105-141, 2004.
14. FIERRO-CARRION, G., D. A. MAHLER, J. WARD J., and J. C. BAIRD. Comparison of continuous and discrete measurements of dyspnea during exercise in patients with COPD and normal subjects. Chest 125:77-84, 2004.
15. HAMILTON, A. L., K. J. KILLIAN, E. SUMMERS E., and N. L. JONES. Symptom intensity and subjective limitation to exercise in patients with cardiorespiratory disorders. Chest 110:1255-1263, 1996.
16. HARTY, H. R., P. HEYWOOD, and L. ADAMS. Comparison between continuous and discrete measurements of breathlessness during exercise in normal subjects using a visual analog scale. Clin. Sci. 85:229-236, 1993.
17. JONES, N. L., E. SUMMERS, and K. J. KILLIAN. Influence of age and stature on exercise capacity during incremental cycle ergometry in men and women. Am. Rev. Respir. Dis. 140:1373-1380, 1989.
18. MAHLER, D. A. G. H. GUYATT, and P. W. JONES. Clinical measurement of dyspnea. In: Dyspnea, D. A. Mahler (Ed.). New York: Marcel Dekker, Inc., 1998, pp. 149-1989.
19. MAHLER, D. A., and A. HARVER. Prediction of peak oxygen consumption in obstructive airway disease. Med. Sci. Sports Exerc. 20:574-578, 1988.
20. MAHLER, D. A., and M. B. HOROWITZ. Perception of breathlessness during exercise in patients with respiratory disease. Med. Sci. Sports Exerc. 26:1078-1081, 1994.
21. MAHLER, D. A., R. MEJIA-ALFARO, J. WARD, and J. C. BAIRD. Continuous measurement of breathlessness during exercise: validity, reliability, and responsiveness. J. Appl. Physiol. 90:2188-2196, 2001.
22. MEDICAL SECTION OF THE AMERICAN LUNG ASSOCIATION. Lung function testing: selection of reference values and interpretative strategies. Am. Rev. Respir. Dis. 144:1202-1218, 1991.
23. O'DONNELL, D. E., T. FLUGE, F. GERKEN, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur. Respir. J. 23:832-840, 2004.
24. O'DONNELL, D. E., M. LAM, and K. A. WEBB. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 158:1557-1565, 1998.
25. O'DONNELL, D. E., N. VODUC, M. FITZPATRICK, and K. A. WEBB. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur. Respir. J. 24:86-94, 2004.
26. OGA, T., K. NISHIMURA, M. TSUKINO, T. HAJIRO, A. IKEDA, and T. IZUMI. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 161:1897-1901, 2000.
27. OGA, T., K. NISHIMURA, M. TSUKINO, S. SATO, T. JAHIRO, and M. MISHIMA. A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD. Chest 123:1810-1816, 2003.
28. STERK, P. J., L. M. FABBRI, P. H. QUANJER, D. W. COCKROFT, P. M. O'BRYNE, and S. D. ANDERSON. Airway responsiveness, standardized challenge testing with pharmacologic, physical and sensitizing stimuli in adults. Eur. Respir. J. 6(Suppl, 16):53S-83S, 1993.
29. TERAMOTO, S., Y. FUKUCHI, and H. ORIMO. Effects of inhaled anticholinergic drug on dyspnea and gas exchange during exercise in patients with chronic obstructive pulmonary disease. Chest 103:1774-1782, 1993.
30. TSUKINO, M., K. NISHIMURA, A. IKEDA A., T. HAJIRO, H. KOYAMA, and T. IZUMI. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. Thorax 53:269-273, 1998.